Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanxinning tablets in stable angina pectoris and pan-vascular disease
ChiCTR2200055916Phase 4Recruiting
- Sponsor
- Hangzhou Hospital of Traditional Chinese Medicine
- Start
- May 2021
- Countries
- 1
01
Overview
Phase 4, randomised trial of Guanxinning in coronary arteriosclerosis and stable angina (2 arms), sponsored by Hangzhou Hospital of Traditional Chinese Medicine. Primary endpoint: Angina Pectoris TCM Syndrome Score. Started May 2021; status: recruiting.
02
Drugs
Guanxinning
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR2200055916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055916.